118 — Rome, Georgia

118 is a clinical research site located in Rome, Georgia, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

118 has participated in 1 clinical trials.

Therapeutic areas: Partial Epilepsies.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rome

Browse all research sites in Georgia · View every site in Rome

• Redmond Regional Hospital
• Harbin Clinic Medical Oncology and Clinical Research
• Regional Radiation Oncology Center at Rome
• Harbin Clinic Cancer Center - Medical Oncology
• Harbin Clinic
• Redmond Regional Medical Center
• InterCommunity Cancer Center at Rome
• GSK Investigational Site
• Research Site
• Prism Research Group
• Local Institution
• Valley Health Care

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 118?

118 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 118 conducted?

118 has 1 clinical trials on record. Their work covers Partial Epilepsies.

Is 118 accredited by Crixeo Clinical Trials?

118 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 118?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.